Pages that link to "Item:Q2353898"

The following pages link to Optimal control for mathematical models of cancer therapies. An application of geometric methods (Q2353898):

Displaying 50 items.

• Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity (Q326554) (← links)
• On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach (Q335265) (← links)
• The role of TNF-\(\alpha\) inhibitor in glioma virotherapy: a mathematical model (Q335279) (← links)
• Identification of some unknown parameters in an aggressive-invasive cancer model using adjoint approach (Q670505) (← links)
• Maximization of viability time in a mathematical model of cancer therapy (Q680444) (← links)
• Optimization of economic indicators with delayed asset commissioning (Q830995) (← links)
• Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy (Q1653067) (← links)
• Dendritic immunotherapy improvement for an optimal control murine model (Q1664521) (← links)
• Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth (Q1678296) (← links)
• Optimal control applied to a generalized Michaelis-Menten model of CML therapy (Q1678312) (← links)
• Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy (Q1696402) (← links)
• Optimal combined radio- and anti-angiogenic cancer therapy (Q1730431) (← links)
• Optimal control of bacterial growth for the maximization of metabolite production (Q1731945) (← links)
• Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
• Optimization of combination therapy for chronic myeloid leukemia with dosing constraints (Q1789085) (← links)
• Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation (Q2002008) (← links)
• On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
• On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
• OptiDose: computing the individualized optimal drug dosing regimen using optimal control (Q2032019) (← links)
• Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
• Optimal strategies in the treatment of cancers in the Lotka-Volterra mathematical model of competition (Q2043626) (← links)
• Optimal control and positional controllability in a one-sector economy (Q2052491) (← links)
• Pitfalls in applying optimal control to dynamical systems: an overview and editorial perspective (Q2081952) (← links)
• Lotka-Volterra competition model with a nonmonotone therapy function for finding optimal strategies in the treatment of blood cancers (Q2095487) (← links)
• Optimization of antitumor radiotherapy fractionation via mathematical modeling with account of 4 R's of radiobiology (Q2109349) (← links)
• Mathematical modeling and control of the cell dynamics in leprosy (Q2130711) (← links)
• Robust optimal control of compartmental models in epidemiology: application to the COVID-19 pandemic (Q2137404) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy (Q2157844) (← links)
• Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control (Q2187010) (← links)
• Optimal control problems for a mathematical model of the treatment of psoriasis (Q2190623) (← links)
• Stability analysis of a class of non-simultaneous interconnected impulsive systems (Q2207821) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy (Q2224757) (← links)
• Global solvability and optimal control to a haptotaxis cancer invasion model with two cancer cell species (Q2234289) (← links)
• Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures (Q2241959) (← links)
• Microscopic description of DNA thermal denaturation (Q2279581) (← links)
• Dynamics of tumor growth: chemotherapy and integrative oncology (Q2301016) (← links)
• Optimal controls of the highly active antiretroviral therapy (Q2303089) (← links)
• On a third-order singular arc of optimal control in a minimization problem for a mathematical model of psoriasis treatment (Q2317232) (← links)
• Open quasispecies models: stability, optimization, and distributed extension (Q2326009) (← links)
• On the role of tumor heterogeneity for optimal cancer chemotherapy (Q2328346) (← links)
• Numerical optimal control of a size-structured PDE model for metastatic cancer treatment (Q2328437) (← links)
• Optimal control and pattern formation for a haptotaxis model of solid tumor invasion (Q2334162) (← links)
• Combination of direct methods and homotopy in numerical optimal control: application to the optimization of chemotherapy in cancer (Q2420794) (← links)
• Control of tumor growth distributions through kinetic methods (Q2659873) (← links)
• Optimizing combination therapy in a murine model of HER2+ breast cancer (Q2679319) (← links)
• On modeling the synergy of cancer immunotherapy with radiotherapy (Q2684058) (← links)
• Optimal control problems for differential equations applied to tumor growth: state of the art (Q2690605) (← links)
• Competition between populations: preventing domination of resistant population using optimal control (Q2692022) (← links)
• Optimal Control Problem of a Metronomic Chemotherapy (Q3297688) (← links)
• Optimal Strategies of the Psoriasis Treatment by Suppressing the Interaction Between T-Lymphocytes and Dendritic Cells (Q3300002) (← links)